Sign In
Buy ALEC
$1.78
-0.175 (-8.97%)
At Close: Jun 03, 2026
Alector Inc (NASDAQ:ALEC) Insider Sells $224,000.00 in Stock
10:12am, Thursday, 06'th Feb 2020
Alector Inc (NASDAQ:ALEC) insider Robert Paul sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $28.00, fo
Alector (NASDAQ:ALEC) Trading 7.1% Higher Following Insider Buying Activity
06:26am, Thursday, 06'th Feb 2020
Alector Inc (NASDAQ:ALEC) shares traded up 7.1% during mid-day trading on Tuesday after an insider bought additional shares in the company. The company traded as high as $31.00 and last traded at $30.
9 Stocks to Buy to Profit Off the Baby Boomer Generation
04:57pm, Wednesday, 05'th Feb 2020
While most investors may focus exclusively on the millennials, it’s the baby boomers that could be the most relevant for Wall Street.
Alector's AL101 Fast Track'd for FTD; shares up 7%
03:54pm, Wednesday, 05'th Feb 2020
The FDA designates Alector's (ALEC +6.8%) AL101 for Fast Track review for the treatment of patients with progranulin gene mutations causing frontotemporal dementia (FTD).Phase 1-stage AL101 is
Alector Announces FDA Fast Track Designation Granted to AL101 for the Treatment of Patients with Frontotemporal Dementia
01:00pm, Wednesday, 05'th Feb 2020
Alector, Inc. (ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AL101 f
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
12:43pm, Wednesday, 05'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
David Wehner Is The Independent Director of Alector, Inc. (NASDAQ:ALEC) And They Just Spent US$500k On Shares
12:21pm, Wednesday, 05'th Feb 2020
Investors who take an interest in Alector, Inc. (NASDAQ:ALEC) should definitely note that the Independent Director...
Trade Alert: The Independent Director Of Alector, Inc. (NASDAQ:ALEC), David Wehner, Has Just Spent US$500k Buying Shares
12:17pm, Wednesday, 05'th Feb 2020
Investors who take an interest in Alector, Inc. (NASDAQ:ALEC) should definitely note that the Independent Director...
Passage Bio Files Initial Plan For IPO
05:10pm, Tuesday, 04'th Feb 2020
Passage Bio has filed to raise $125 million in an IPO, although the final figure may differ. The firm is advancing a pipeline of genetic treatment candidates fo
Alector Inc (NASDAQ:ALEC) Director David M. Wehner Purchases 20,000 Shares
09:18am, Tuesday, 04'th Feb 2020
Alector Inc (NASDAQ:ALEC) Director David M. Wehner bought 20,000 shares of the business’s stock in a transaction dated Monday, February 3rd. The shares were bought at an average cost of $28.19 per s
Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic
04:12am, Tuesday, 04'th Feb 2020
A year ago Passage Bio launched with $115.5 million and plans to advance a handful of gene therapies discovered at the University of Pennsylvania. Now the
Alector, Inc. (ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced the closing of its previously announced underwritten public offering of 9,602,500 shares of it
- Total gross proceeds from the offering to Alector are approximately $240 million
Alector (NASDAQ:ALEC) Sees Unusually-High Trading Volume
09:16am, Sunday, 02'nd Feb 2020
Alector Inc (NASDAQ:ALEC) saw unusually-strong trading volume on Friday . Approximately 26,062 shares traded hands during trading, a decline of 94% from the previous session’s volume of 440,545 shar
Zacks Investment Research Lowers Alector (NASDAQ:ALEC) to Hold
07:04am, Sunday, 02'nd Feb 2020
Alector (NASDAQ:ALEC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Friday, Zacks.com reports. According to Zacks, “Alector Inc.
